We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-4.95%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.9B
AUM Growth
-$320M
Cap. Flow
-$202M
Cap. Flow %
-10.62%
Top 10 Hldgs %
7.71%
Holding
2,190
New
419
Increased
603
Reduced
646
Closed
510

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$17.7M
2
SBUX icon
Starbucks
SBUX
+$16.5M
3
WMB icon
Williams Companies
WMB
+$15.6M
4
HRI icon
Herc Holdings
HRI
+$14.9M
5
DAL icon
Delta Air Lines
DAL
+$14M

Top Sells

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$24.9M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$15.2M
3
TJX icon
TJX Companies
TJX
+$14.9M
4
DD
Du Pont De Nemours E I
DD
+$14.4M
5
CTRA
Coterra Energy
CTRA
+$14.2M

Sector Composition

Rank Sector Weight
1 Healthcare 14.76%
2 Consumer Discretionary 13.95%
3 Industrials 12.6%
4 Technology 11%
5 Energy 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APA icon
151
APA Corp
APA
$13.2B
$2.53M 0.13%
+26,953
New +$2.67M
EQR icon
152
Equity Residential
EQR
$24.9B
$2.52M 0.13%
40,939
+19,432
+90% +$1.26M
BNY
153
Bank of New York Mellon
BNY
$106B
$2.51M 0.13%
+64,748
New +$2.52M
AVB icon
154
AvalonBay Communities
AVB
$26.5B
$2.5M 0.13%
17,767
+4,514
+34% +$670K
DOC icon
155
Healthpeak Properties
DOC
$15.1B
$2.5M 0.13%
69,042
-41,575
-38% -$1.58M
CTSH icon
156
Cognizant
CTSH
$24.9B
$2.48M 0.13%
+55,377
New +$2.61M
PDLI
157
DELISTED
PDL BioPharma, Inc.
PDLI
$2.44M 0.13%
326,577
+83,705
+34% +$777K
NBR icon
158
Nabors Industries
NBR
$1.27B
$2.43M 0.13%
2,133
-7
-0.3% -$9.31K
BTU
159
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$2.42M 0.13%
13,009
+12,145
+1,406% +$2.76M
AGNC icon
160
AGNC Investment
AGNC
$12.4B
$2.41M 0.13%
113,370
+1,263
+1% +$29.1K
WELL icon
161
Welltower
WELL
$169B
$2.4M 0.13%
38,497
-23,917
-38% -$1.54M
TECH icon
162
Bio-Techne
TECH
$11.2B
$2.39M 0.13%
102,128
+30,400
+42% +$713K
TIF
163
DELISTED
Tiffany & Co.
TIF
$2.35M 0.12%
24,375
+7,004
+40% +$698K
IQV icon
164
IQVIA
IQV
$38.7B
$2.34M 0.12%
41,969
+28,830
+219% +$1.61M
AKRX
165
DELISTED
Akorn Inc
AKRX
$2.34M 0.12%
+64,515
New +$2.31M
PLD icon
166
Prologis
PLD
$135B
$2.33M 0.12%
61,738
-67,146
-52% -$2.72M
OUT icon
167
Outfront Media
OUT
$5.61B
$2.32M 0.12%
+103,472
New +$2.53M
INTC icon
168
Intel
INTC
$455B
$2.3M 0.12%
+66,107
New +$2.24M
EBS icon
169
Emergent Biosolutions
EBS
$373M
$2.27M 0.12%
106,627
+23,234
+28% +$532K
AMD icon
170
Advanced Micro Devices
AMD
$776B
$2.25M 0.12%
659,914
+467,016
+242% +$1.89M
CCEP icon
171
Coca-Cola Europacific Partners
CCEP
$48.3B
$2.25M 0.12%
+50,625
New +$2.37M
CHRD icon
172
Chord Energy
CHRD
$7.9B
$2.24M 0.12%
+53,593
New +$2.67M
EEFT icon
173
Euronet Worldwide
EEFT
$2.72B
$2.24M 0.12%
46,808
+29,738
+174% +$1.48M
NLY icon
174
Annaly Capital Management
NLY
$17.1B
$2.23M 0.12%
52,146
+4,007
+8% +$183K
JOY
175
DELISTED
Joy Global Inc
JOY
$2.23M 0.12%
40,849
+29,946
+275% +$1.82M
5 6
7
8 9

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's Q3 2014 Portfolio in Review

As of Q3 2014, GSA Capital Partners held 2,190 positions worth $1.9B, down 14% from $2.22B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

GSA Capital Partners withdrew a net $202M in Q3 2014, closing 510 positions and reducing 646 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, GSA Capital Partners opened a new position in Illumina worth $16.9M.

  • GSA Capital Partners's largest Q3 2014 buy was Illumina: 105,983 shares worth $16.9M.
  • GSA Capital Partners added most to Williams Companies in Q3 2014, an estimated $15.6M increase.
  • GSA Capital Partners's biggest Q3 2014 reduction was Marathon Petroleum, cutting an estimated $24.9M.
  • GSA Capital Partners fully exited Regeneron Pharmaceuticals in Q3 2014, selling an estimated $15.2M.
  • GSA Capital Partners's ten largest holdings make up 7.7% of its $1.9B portfolio in Q3 2014.
  • GSA Capital Partners opened 419 new positions and closed 510 in Q3 2014.
  • GSA Capital Partners's portfolio value fell 14% quarter-over-quarter to $1.9B.

Based on GSA Capital Partners's 13F filing for Q3 2014, filed 6 Nov 2014.